Funded Tech Companies
Targacept
Looking for the VC firms that invested in Targacept? Nomura Phase4 Ventures, Advent International and New Enterprise Associates invested in this biopharmaceutical company.
Company Overview
Company Name
Targacept
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
100 North Main St. 1510
Winston-Salem, NC 27101
USA
Winston-Salem, NC 27101
USA
Phone
Website
Email Address
Company Background Information
Overview
Targacept, Inc. (Nasdaq: TRGT) is a world leader in the discovery and development of nicotinic acetylcholine receptor-based therapies for neurodegenerative, neuropsychiatric and gastrointestinal diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/8/2004
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nassim Usman
Chief Financial Officer
Fletcher Payne
Chief Medical Officer
Howard Levy
VP - Bus. Development
Jeffrey Landau
VP - Manufacturing
Andrew Hetherington
Company Investors
- Nomura Phase4 Ventures
- Advent International
- New Enterprise Associates
- Rally Ventures
- Burrill & Company
- Easton Capital
- Oxford Bioscience Partners (Alan Walton)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs